Unknown

Dataset Information

0

Quantification of NADPH: cytochrome P-450 reductase in liver microsomes by a specific radioimmunoassay technique.


ABSTRACT: We have developed a specific radioimmunoassay to quantify NADPH: cytochrome P-450 reductase. The assay is based on the use of 125I-labelled NADPH: cytochrome P-450 reductase as the radiolabelled antigen and can detect quantities of this protein in amounts as low as 30 pg. The results of the radioimmunoassay demonstrates that the 2.7-fold increase in enzyme activity in rat liver microsomal membranes after phenobarbital treatment is due to increased amounts of the protein. beta-Naphthoflavone treatment, however, did not alter the activity or the quantity of this enzyme in microsomes. The quantification of NADPH: cytochrome P-450 reductase in the microsomes isolated from control and phenobarbital- and beta-naphthoflavone-treated animals permits the calculation of the ratio of this protein to that of total cytochromes P-450. A molar ratio of 15:1 (cytochromes P-450/NADPH: cytochrome P-450 reductase) was calculated for control and phenobarbital-treated animals. This ratio increased to 21:1 after beta-naphthoflavone treatment. Thus the molar ratio of these proteins in liver microsomes can vary with exposure of the animals to particular xenobiotics.

SUBMITTER: Shephard EA 

PROVIDER: S-EPMC1154364 | biostudies-other | 1983 May

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC1217696 | biostudies-other
| S-EPMC1147453 | biostudies-other
| S-EPMC1162154 | biostudies-other
| S-EPMC3269586 | biostudies-literature
| S-EPMC6438780 | biostudies-literature
| S-EPMC1146696 | biostudies-other
| S-EPMC1183744 | biostudies-other
| S-EPMC1146921 | biostudies-other
| S-EPMC1138594 | biostudies-other
| S-EPMC1153262 | biostudies-other